<DOC>
	<DOCNO>NCT01742663</DOCNO>
	<brief_summary>The objective study compare relative efficacy safety test formulation diclofenac sodium gel 3 % ( Taro Pharmaceuticals Inc. ) market formulation Solaraze® ( diclofenac sodium ) Gel 3 % ( Fougera Pharms ) treatment actinic keratosis . Both test reference formulation also compare placebo formulation test superiority .</brief_summary>
	<brief_title>A Study Comparing Diclofenac Sodium Gel 3 % Solaraze® Gel 3 % Treatment Actinic Keratosis</brief_title>
	<detailed_description />
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis , Actinic</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<criteria>Signed informed consent form . Immunocompetent male nonpregnant , nonlactating female least 18 year age . Diagnosis AK least 5 10 clinically typical , visable , discrete , nonhyperkeratotic , nonhypertrophic AK lesion least 4 mm diameter face and/or bald scalp contain within 25 cm2 treatment area . Women either must 1 year postmenopausal , surgically sterile , childbearing potential must use systemic birth control , IUD Norplant least 28 day prior treatment start , use barrier method consistently least 14 day study gel administration , normal menstrual cycle month prior start treatment , negative urine pregnancy test result upon entry study agree use medically accept form birth control throughout study period . Free systemic dermatologic disorder , opinion investigator , interfere study result increase risk AEs . Any skin type race , provide skin pigmentation allow discernment erythema . Willingness capability cooperate extent degree require protocol . Active gastrointestinal ulceration bleeding . Current history severe renal hepatic impairment . Presence atopic dermatitis , basal cell carcinoma , squamous cell carcinoma , eczema , psoriasis , rosacea , sunburn possible confound skin condition face bald scalp . Use within six month prior randomization oral isotretinoin . Use within six month prior baseline face bald scalp chemical peel , dermabrasion , laser abrasion , PUVA therapy UVB therapy . Use within one month prior baseline face bald scalp cryodestruction chemodestruction , curettage , photodynamic therapy , surgical excision , topical 5fluorouracil , topical corticosteroid , topical diclofenac , topical Imiquimod , topical retinoids treatment actinic keratosis include glycolic acid overthecounter product contain retinol , alpha beta hydroxy acid . Use within one month prior baseline immunomodulators immunosuppressive therapy , interferon , systemic corticosteroid cytotoxic drug . Known allergy diclofenac sodium , benzyl alcohol , polyethylene glycol monomethyl ether 359 , hyaluronate sodium excipients test reference gel . Receiving 5Fluorouracil systemic cancer chemotherapy within 6 month prior study entry . Any condition , medical , psychological social , , investigator 's opinion , would interfere participation study . Women pregnant planning pregnancy lactate study . Participation investigational drug study within 30 day enrollment previous participation study . Employees family member employee research center investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Diclofenac Sodium Gel 3 %</keyword>
	<keyword>Solaraze® ( diclofenac sodium ) Gel 3 %</keyword>
	<keyword>Actinic Keratosis</keyword>
</DOC>